Single-Cell Transcriptomic Analysis of Tumor-Derived Fibroblasts and Normal Tissue-Resident Fibroblasts Reveals Fibroblast Heterogeneity in Breast Cancer
Open accessThe DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Abstract
Cancer-associated fibroblasts (CAFs) are a prominent stromal cell type in solid tumors and molecules secreted by CAFs play an important role in tumor progression and metastasis. CAFs coexist as heterogeneous populations with potentially different biological functions. Although CAFs are a major component of the breast cancer stroma, molecular and phenotypic heterogeneity of CAFs in breast cancer is poorly understood. In this study, we investigated CAF heterogeneity in triple-negative breast cancer (TNBC) using a syngeneic mouse model, BALB/c-derived 4T1 mammary tumors. Using single-cell RNA sequencing (scRNA-seq), we identified six CAF subpopulations in 4T1 tumors including: 1) myofibroblastic CAFs, enriched for α-smooth muscle actin and several other contractile proteins; 2) ‘inflammatory’ CAFs with elevated expression of inflammatory cytokines; and 3) a CAF subpopulation expressing major histocompatibility complex (MHC) class II proteins that are generally expressed in antigen-presenting cells. Comparison of 4T1-derived CAFs to CAFs from pancreatic cancer revealed that these three CAF subpopulations exist in both tumor types. Interestingly, cells with inflammatory and MHC class II-expressing CAF profiles were also detected in normal breast/pancreas tissue, suggesting that these phenotypes are not tumor microenvironment-induced. This work enhances our understanding of CAF heterogeneity, and specifically targeting these CAF subpopulations could be an effective therapeutic approach for treating highly aggressive TNBCs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
IL-6 secreted by cancer-associated fibroblasts induces tamoxifen resistance in luminal breast cancer
Sun, X., Mao, Y., Wang, J., Zu, L., Hao, M., Cheng, G., Qu, Q., Cui, D., Keller, E. T., Chen, X., et al. (2014) · Oncogene · doi:10.1038/onc.2014.158 · Cited by 75
RetractedComprehensive Integration of Single-Cell Data
Stuart, T., Butler, A., Hoffman, P., Hafemeister, C., Papalexi, E., Mauck, W. M., Hao, Y., Stoeckius, M., Smibert, P., & Satija, R. (2019) · Cell · doi:10.1016/j.cell.2019.05.031 · Cited by 15,453
Integrating single-cell transcriptomic data across different conditions, technologies, and species
Butler, A., Hoffman, P., Smibert, P., Papalexi, E., & Satija, R. (2018) · Nature Biotechnology · doi:10.1038/nbt.4096 · Cited by 13,174 · cited 16×
“Expression data, phenotype data, and feature data were extracted from the Seurat object and a Monocle “CellDataSet” object was constructed using the “newCellDataSet” function.”
MethodInfluentialTrapnell, C., Cacchiarelli, D., Grimsby, J., Pokharel, P., Li, S., Morse, M., Lennon, N. J., Livak, K. J., Mikkelsen, T. S., & Rinn, J. L. (2014) · Nature Biotechnology · doi:10.1038/nbt.2859 · Cited by 7,314 · cited 6×
“Expression data, phenotype data, and feature data were extracted from the Seurat object and a Monocle “CellDataSet” object was constructed using the “newCellDataSet” function.”
MethodInfluentialÖzdemir, B. C., Pentcheva-Hoang, T., Carstens, J. L., Zheng, X., Wu, C.-C., Simpson, T. R., Laklai, H., Sugimoto, H., Kahlert, C., Novitskiy, S. V., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.04.005 · Cited by 2,681 · cited 1×
“These findings suggest that α-SMAhigh CAFs may also function to keep the tumor in check [61].”
BackgroundHingorani, S. R., Wang, L., Multani, A. S., Combs, C., Deramaudt, T. B., Hruban, R. H., Rustgi, A. K., Chang, S., & Tuveson, D. A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.04.023 · Cited by 2,609
Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer
Öhlund, D., Handly-Santana, A., Biffi, G., Elyada, E., Almeida, A. S., Ponz-Sarvise, M., Corbo, V., Oni, T. E., Hearn, S. A., Lee, E. J., et al. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20162024 · Cited by 2,590
Elyada, E., Bolisetty, M., Laise, P., Flynn, W. F., Courtois, E. T., Burkhart, R. A., Teinor, J. A., Belleau, P., Biffi, G., Lucito, M. S., et al. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-0094 · Cited by 2,241 · cited 10×
“have shown the presence of apCAFs in both mouse and human PDAC samples [15].”
BackgroundMethodResultInfluentialTRANSFORMING GROWTH FACTOR-β REGULATION OF IMMUNE RESPONSES
Li, M. O., Wan, Y. Y., Sanjabi, S., Robertson, A.-K. L., & Flavell, R. A. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.24.021605.090737 · Cited by 2,206
Organoid models of human and mouse ductal pancreatic cancer
Boj, S. F., Hwang, C.-I., Baker, L. A., Chio, I. I. C., Engle, D. D., Corbo, V., Jager, M., Ponz-Sarvise, M., Tiriac, H., Spector, M. S., et al. (2015) · Cell · doi:10.1016/j.cell.2014.12.021 · Cited by 2,150 · cited 3×
“The mT3 cell line was developed from organoids isolated from KPC mouse PDAC lesions [23].”
BackgroundMethodHinz, B., Phan, S. H., Thannickal, V. J., Galli, A., Bochaton-Piallat, M.-L., & Gabbiani, G. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.070112 · Cited by 2,068
Bauer, K. R., Brown, M., Cress, R. D., Parise, C. A., & Caggiano, V. (2007) · Cancer · doi:10.1002/cncr.22618 · Cited by 2,067
Fibroblast Heterogeneity and Immunosuppressive Environment in Human Breast Cancer
Costa, A., Kieffer, Y., Scholer-Dahirel, A., Pelon, F., Bourachot, B., Cardon, M., Sirven, P., Magagna, I., Fuhrmann, L., Bernard, C., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.01.011 · Cited by 1,705
Biffi, G., Oni, T. E., Spielman, B., Hao, Y., Elyada, E., Park, Y., Preall, J., & Tuveson, D. A. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-0710 · Cited by 1,360
Global cancer in women: burden and trends.
Torre, L. A., Islami, F., Siegel, R. L., Ward, E. M., & Jemal, A. (2017) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-16-0858 · Cited by 1,245
Li, H., Courtois, E. T., Sengupta, D., Tan, Y., Chen, K. H., Goh, J. J. L., Kong, S. L., Chua, C., Hon, L. K., Tan, W. S., et al. (2017) · Nature Genetics · doi:10.1038/ng.3818 · Cited by 1,080
Cancer-associated fibroblasts: an emerging target of anti-cancer immunotherapy
Liu, T., Han, C., Wang, S., Fang, P., Ma, Z., Xu, L., & Yin, R. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0770-1 · Cited by 860 · cited 2×
“CAF markers Pdpn, Thy1 and Pdgfra [25] and CAF-secreted collagens Col1a1 and Col3a1 were expressed in all these clusters (Figure 2B).”
BackgroundDominguez, C. X., Müller, S., Keerthivasan, S., Koeppen, H., Hung, J., Gierke, S., Breart, B., Foreman, O., Bainbridge, T. W., Castiglioni, A., et al. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-0644 · Cited by 857
Bartoschek, M., Oskolkov, N., Bocci, M., Lövrot, J., Larsson, C., Sommarin, M., Madsen, C. D., Lindgren, D., Pekar, G., Karlsson, G., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07582-3 · Cited by 826 · cited 6×
“It is possible that these populations shift as the tumor grows in size, as it acquires resistance to therapy, or as it metastasizes [16].”
BackgroundInfluentialCancer-Associated Fibroblasts: Their Characteristics and Their Roles in Tumor Growth
Shiga, K., Hara, M., Nagasaki, T., Sato, T., Takahashi, H., & Takeyama, H. (2015) · Cancers · doi:10.3390/cancers7040902 · Cited by 774 · cited 2×
“Previously it has been shown that resident tissue fibroblasts, bone marrow-derived mesenchymal stem cells, hematopoietic stem cells, adipocytes and endothelial cells can all give rise to CAFs, each by different mechanisms [5,6].”
BackgroundAn overview of triple-negative breast cancer
Kumar, P., & Aggarwal, R. (2016) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-015-3859-y · Cited by 771
Procollagen trafficking, processing and fibrillogenesis
Canty, E. G., & Kadler, K. E. (2005) · Journal of Cell Science · doi:10.1242/jcs.01731 · Cited by 764
Carcinoma-associated fibroblasts: orchestrating the composition of malignancy
Gascard, P., & Tlsty, T. D. (2016) · Genes & Development · doi:10.1101/gad.279737.116 · Cited by 732
Identification of fibroblast heterogeneity in the tumor microenvironment
Sugimoto, H., Mundel, T. M., Kieran, M. W., & Kalluri, R. (2006) · Cancer Biology & Therapy · doi:10.4161/cbt.5.12.3354 · Cited by 699
Cancer associated fibroblasts: the dark side of the coin.
Cirri, P., & Chiarugi, P. (2011) · Europe PMC (PubMed Central) · Cited by 669
Guerrero-Juarez, C. F., Dedhia, P. H., Jin, S., Ruiz-Vega, R., Ma, D., Liu, Y., Yamaga, K., Shestova, O., Gay, D. L., Yang, Z., et al. (2019) · Nature Communications · doi:10.1038/s41467-018-08247-x · Cited by 521 · cited 1×
“The α-SMAhigh cluster (cluster 1), had a molecular signat re similar to the myofibroblasts, which have been show to play crucial roles in wound healing and pathological tissue remodeling [42,43].”
BackgroundVEGF-A and the Induction of Pathological Angiogenesis
Nagy, J. A., Dvorak, A. M., & Dvorak, H. F. (2007) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.2.010506.134925 · Cited by 474
PAULIN, D., & LI, Z. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.08.004 · Cited by 451
Cancer-Associated Fibroblasts Build and Secure the Tumor Microenvironment
Liu, T., Zhou, L., Li, D., Andl, T., & Zhang, Y. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00060 · Cited by 446 · cited 1×
“CAFs have been shown to play a major role in extracellular matrix (ECM) synthesis and organization [28].”
BackgroundTsuyada, A., Chow, A., Wu, J., Somlo, G., Chu, P., Loera, S., Luu, T., Li, A. X., Wu, X., Ye, W., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3567 · Cited by 407
TGF-β1-mediated fibroblast–myofibroblast terminal differentiation—the role of smad proteins
Evans, R. A., Tian, Y. A. C., Steadman, R., & Phillips, A. O. (2003) · Experimental Cell Research · doi:10.1016/s0014-4827(02)00015-0 · Cited by 398
Nagasaki, T., Hara, M., Nakanishi, H., Takahashi, H., Sato, M., & Takeyama, H. (2014) · British Journal of Cancer · doi:10.1038/bjc.2013.748 · Cited by 385
Unravelling biology and shifting paradigms in cancer with single-cell sequencing
Baslan, T., & Hicks, J. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.58 · Cited by 381
Wu, X., Tao, P., Zhou, Q., Li, J., Yu, Z., Wang, X., Li, J., Li, C., Yan, M., Zhu, Z., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.15119 · Cited by 367
Development and applications of single-cell transcriptome analysis
Tang, F., Lao, K., & Surani, M. A. (2011) · Nature Methods · doi:10.1038/nmeth.1557 · Cited by 338
Mechanisms of the Epithelial–Mesenchymal Transition by TGF-β
Wendt, M. K., Allington, T. M., & Schiemann, W. P. (2009) · Future Oncology · doi:10.2217/fon.09.90 · Cited by 317
Ly6 family proteins in neutrophil biology
Lee, P. Y., Wang, J.-X., Parisini, E., Dascher, C. C., & Nigrovic, P. A. (2013) · Journal of Leukocyte Biology · doi:10.1189/jlb.0113014 · Cited by 303
Hosein, A. N., Huang, H., Wang, Z., Parmar, K., Du, W., Huang, J., Maitra, A., Olson, E., Verma, U., & Brekken, R. A. (2019) · JCI Insight · doi:10.1172/jci.insight.129212 · Cited by 302
Triple‐negative breast cancer: Present challenges and new perspectives
Podo, F., Buydens, L. M. C., Degani, H., Hilhorst, R., Klipp, E., Gribbestad, I. S., Van Huffel, S., W.M. van Laarhoven, H., Luts, J., Monleon, D., et al. (2010) · Molecular Oncology · doi:10.1016/j.molonc.2010.04.006 · Cited by 299
Shintani, Y., Fujiwara, A., Kimura, T., Kawamura, T., Funaki, S., Minami, M., & Okumura, M. (2016) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2016.05.025 · Cited by 293
Type XIV Collagen Regulates Fibrillogenesis
Ansorge, H. L., Meng, X., Zhang, G., Veit, G., Sun, M., Klement, J. F., Beason, D. P., Soslowsky, L. J., Koch, M., & Birk, D. E. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m805582200 · Cited by 195
Ebbing, E. A., van der Zalm, A. P., Steins, A., Creemers, A., Hermsen, S., Rentenaar, R., Klein, M., Waasdorp, C., Hooijer, G. K. J., Meijer, S. L., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1820459116 · Cited by 182
The Role of Stroma in Tumor Development
Werb, Z., & Lu, P. (2015) · The Cancer Journal · doi:10.1097/ppo.0000000000000127 · Cited by 176
Fibronectin: How Its Aberrant Expression in Tumors May Improve Therapeutic Targeting
Wang, J. P., & Hielscher, A. (2017) · Journal of Cancer · doi:10.7150/jca.16901 · Cited by 167
The role of CXCL12 in tumor microenvironment
Meng, W., Xue, S., & Chen, Y. (2018) · Gene · doi:10.1016/j.gene.2017.10.015 · Cited by 159
Fibronectin-targeted drug delivery in cancer
Kumra, H., & Reinhardt, D. P. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.11.014 · Cited by 157
Galectin-3 and cancer stemness
Nangia‐Makker, P., Hogan, V. A., & Raz, A. (2018) · Glycobiology · doi:10.1093/glycob/cwy001 · Cited by 152
Gandellini, P., Andriani, F., Merlino, G., D’Aiuto, F., Roz, L., & Callari, M. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.08.008 · Cited by 149
Itano, N., Sawai, T., Atsumi, F., Miyaishi, O., Taniguchi, S., Kannagi, R., Hamaguchi, M., & Kimata, K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313178200 · Cited by 138
Rick, J. W., Chandra, A., Ore, C. L. D., Nguyen, A. T., Yagnik, G., & Aghi, M. K. (2019) · Seminars in Oncology · doi:10.1053/j.seminoncol.2019.08.002 · Cited by 136
Zhang, J., Chen, L., Xiao, M., Wang, C., & Qin, Z. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2010.11.017 · Cited by 116
Differing Roles of Hyaluronan Molecular Weight on Cancer Cell Behavior and Chemotherapy Resistance
Price, Z. K., Lokman, N. A., & Ricciardelli, C. (2018) · Cancers · doi:10.3390/cancers10120482 · Cited by 104
Placental growth factor in cancer
Dewerchin, M. A., & Carmeliet, P. (2014) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2014.948420 · Cited by 90
Jeannin, P., Duluc, D., & Delneste, Y. (2011) · Immunotherapy · doi:10.2217/imt.11.30 · Cited by 88
Cancer-stromal interactions: Role in cell survival, metabolism and drug sensitivity
Zhang, W., & Huang, P. (2011) · Cancer Biology & Therapy · doi:10.4161/cbt.11.2.14623 · Cited by 80
Sharon, Y., Alon, L., Glanz, S., Servais, C., & Erez, N. (2013) · Journal of Visualized Experiments · doi:10.3791/4425 · Cited by 75
Hu, X., Li, Y.-Q., Li, Q.-G., Ma, Y.-L., Peng, J.-J., & Cai, S.-J. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0718-2 · Cited by 75
Xu, T., Zhang, R., Dong, M., Zhang, Z., Li, H., Zhan, C., & Li, X. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s222967 · Cited by 72
Gorchs, L., Hellevik, T., Bruun, J.-A., Camilio, K.-A., Al-Saad, S., Stuge, T.-B., & Martinez-Zubiaurre, I. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00087 · Cited by 71
Interleukin-33 in Malignancies: Friends or Foes?
Shen, J., Liu, J., & Zhang, G. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.03051 · Cited by 67
New strategy to control cell migration and metastasis regulated by CCN2/CTGF
Aguiar, D. P., de Farias, G. C., de Sousa, E. B., de Mattos Coelho-Aguiar, J., Lobo, J. C., Casado, P. L., Duarte, M. E. L., & Abreu, J. G. R. (2014) · Cancer Cell International · doi:10.1186/1475-2867-14-61 · Cited by 50
Ex Vivo Detection of Circulating Tumor Cells from Whole Blood by Direct Nanoparticle Visualization
Sobral-Filho, R. G., DeVorkin, L., MacPherson, S., Jirasek, A. I., Lum, J. J., & Brolo, A. G. (2018) · ACS Nano · doi:10.1021/acsnano.7b08813 · Cited by 42
Hu, J., Duan, B., Jiang, W., Fu, S., Gao, H., & Lu, L. (2019) · Cancer Medicine · doi:10.1002/cam4.2144 · Cited by 40
Sarkar, A., Chanda, A., Regmi, S. C., Karve, K., Deng, L., Jay, G. D., Jirik, F. R., Schmidt, T. A., & Bonni, S. (2019) · PLoS ONE · doi:10.1371/journal.pone.0219697 · Cited by 39
Pericytes and their potential in regenerative medicine across species
Esteves, C. L., & Donadeu, F. X. (2017) · Cytometry Part A · doi:10.1002/cyto.a.23243 · Cited by 38
Comparative Molecular Analysis of Cancer Behavior Cultured In Vitro, In Vivo, and Ex Vivo
Hum, N. R., Sebastian, A., Gilmore, S. F., He, W., Martin, K. A., Hinckley, A., Dubbin, K., Moya, M. L., Wheeler, E. K., Coleman, M. A., et al. (2020) · Cancers · doi:10.3390/cancers12030690 · Cited by 38
Self-citationBrauer, R., Beck, I. M., Roderfeld, M., Roeb, E., & Sedlacek, R. (2011) · BMC Biochemistry · doi:10.1186/1471-2091-12-38 · Cited by 36
Hu, C., Wang, Z., Zhai, L., Miling, Y., Shan, L., Chai, C., Liu, M., & Wang, L. (2012) · Oncology Letters · doi:10.3892/ol.2012.1023 · Cited by 29
Single-cell analysis on stromal fibroblasts in the microenvironment of solid tumours
Musa, M. (2020) · Advances in Medical Sciences · doi:10.1016/j.advms.2019.12.001 · Cited by 26
The pericyte antigen RGS5 in perivascular soft tissue tumors
Shen, J., Shrestha, S., Yen, Y.-H., Scott, M., Soo, C. B., Ting, K., Péault, B., Dry, S., & James, A. W. (2015) · Human Pathology · doi:10.1016/j.humpath.2015.09.013 · Cited by 25
Cited by
Mao, X., Xu, J., Wang, W., Liang, C., Hua, J., Liu, J., Zhang, B., Meng, Q., Yu, X., & Shi, S. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01428-1 · Cited by 2,290
“iCAFs Ly6c1, CLEC3B, HAS1, DPT and COL14A1 Tumor proliferation, Metastasis, Angiogenesis, Immune evasion and Chemoresistance [99]”
BackgroundInfluentialSignaling pathways in cancer-associated fibroblasts and targeted therapy for cancer
Wu, F., Yang, J., Liu, J., Wang, Y., Mu, J., Zeng, Q., Deng, S., & Zhou, H. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00641-0 · Cited by 773
Cancer-associated fibroblasts in the single-cell era
Lavie, D., Ben-Shmuel, A., Erez, N., & Scherz-Shouval, R. (2022) · Nature Cancer · doi:10.1038/s43018-022-00411-z · Cited by 616
Cancer-associated fibroblasts: from basic science to anticancer therapy
Yang, D., Liu, J., Qian, H., & Zhuang, Q. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-01013-0 · Cited by 572
Fibroblasts in cancer: Unity in heterogeneity
Chhabra, Y., & Weeraratna, A. T. (2023) · Cell · doi:10.1016/j.cell.2023.03.016 · Cited by 474
Metadata
- Authors
- Sebastian, A., Hum, N. R., Martin, K. A., Gilmore, S. F., Peran, I., Byers, S. W., Wheeler, E. K., Coleman, M. A., & Loots, G. G.
- Venue
- Cancers
- Publisher
- MDPI AG
- Published
- 2020-05-21
- Volume
- 12
- Issue
- 5
- Pages
- 1307
- ISSN
- 2072-6694 (ISSN-L)
- OpenAlex
- W3026654828
- Cited by
- 260
- References
- 70
- FWCI
- 9.34
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.